Upcoming events from UBM India in data integrity, pharma and manufacturing domains

Top Quote UBM India is one of the India's leading event manager is coming up with series of events in pharma, audits and data integrity domains with venues in India and Dubai. Goevnts is partnering UBM India as Official media partner to promote their events. End Quote
  • (1888PressRelease) August 10, 2015 - The following events are coming up soon : The 2nd Annual Manufacturing Excellence India Summit will be the place where manufacturing industry's game changers will meet, discuss and envision the best possible way for Indian Manufacturing sector to transform and move towards sustainable growth and prosperity. With a back drop of a successful inaugural Manufacturing Excellence Summit (MAFEX) summit 2014, this year's event will be more focused towards providing the most practical answers to the most relevant questions which a manufacturing leader has to come across on a daily basis.

    -- Spate of 'import alerts', export bans and warning letters (Form 483) over the last two years have unexpectedly increased. And these were issued mainly during surprise audits conducted by the global regulatory authorities.

    Indian Pharma accounts for the highest number warning letters issued by the USFDA at the same time it also accounts for nearly 40% imports by the US market. At this juncture it is extremely important to bring synchronization amongst the two. Keeping this in mind CPhI India brings you a two day workshop on "unannounced audits". The event is scheduled on 25-26 August in Mumbai and 27-28 August in Ahmedabad. This two day workshop will provide you insights on strategies to handle unannounced audits and be prepared for it at any point of time.

    --With stringent drug formulation requirements by the Global regulatory authorities, Pharmaceutical companies are on the lookout for newer and effective formulation practices. CPhI's Global Drug Formulations Summit will focus on the challenges and considerations in developing drug formulations that are faced by Global Pharmaceutical companies. The summit aims to address, the top three formulation issues - bioavailability, stability issues, and solubility. The event will bring together more than 100 decision makers to provide an insight into advancing technologies for safer drugs. Featuring workshop and case studies, this is a platform to get best solutions to the drug formulation concerns faced by your company and also an excellent opportunity to network with industry experts from prominent companies.

    --With the ever evolving SCM requirements and regulatory framework, now is the right time for the pharmaceutical product manufacturers to learn to cope with complex regulatory demands on serialisation and track and trace, leveraging the latest developments in cold chain warehousing infrastructure, 3PL logistics, supply chain IT that will enable cost optimisation and formulate successful production planning.

    Keeping in mind that, the constant pressure for innovation has made pharma supply chains increasingly complex, CPhI's 6th Annual Pharma Supply Chain has been designed to provide pharma supply chain and logistics solution that are more coherent and profitable in the way forward.

    --The 'Make in India' campaign will see investments would connect India to global production networks and would generate significant new business for logistics in India and is looking forward to another a promising year with great hopes, plans and aspirations. Project cargo clearly drives the heavy-lift sector. In terms of sophistication, the equipment and technologies available in the logistics industry in India do not compare very favorably with those abroad.

    UBM's Project Cargo India 2015 shall bring together the industry, trade and the government to discuss and debate on the most pressing issues under Project Cargo end-to-end services and learn the latest techniques to manage heavy lift and project cargo transportation.

    --India stands second in terms of the number of pharmaceutical manufacturing facilities outside the US i.e. 523 and accounts for nearly 40 percent of the US drug imports. Considering this it is essential for the Indian Pharmaceutical companies to comply by the USFDA norms.

    It has been observed that India accounts for majority of the warning letters being issued mainly because of data integrity issues. The USFDA has issued 8 out of 19 USFDA warning letters as of 2014 in India and 6 warning letters as of 2015 the reason being quality system failures and not adhering to GMP standards. Shortage of manpower, compromising acceptable quality levels to meet production targets or dispatch time-lines, cultural differences and lack of understanding of good manufacturing practices (GMP) are some of the basic reasons behind data integrity issues faced by Indian pharmaceutical companies.

    Taking all this into consideration, CPhI India in association with Lachman Consultants brings you the2nd Annual Data Integrity, Reliability & Quality metrics workshop in Hyderabad & Mumbai on 26-27 October & 29-30 October respectively which will address the data integrity concerns of pharmaceutical companies.

    --CPhI Conferences Quality Audits and Data Integrity play a significant role in the organization's Quality management system to ensure a continuous improvement program in the organization. It is a critical issue which needs to be resolved at the earliest to avoid severe penalties, warning letters and import alerts in future which might result in the loss of reputation and plant.

    Taking this into consideration, CPhI Conferences brings you a 2 day practical workshop on Quality Audits and Data Integrity on 28th - 29th September 2015 in Dubai to address quality and data integrity concerns of pharmaceutical companies.

  • FB Icon Twitter Icon In-Icon
Contact Information